Clinical Trials Directory

Trials / Sponsors / Fundacion SEIMC-GESIDA

Fundacion SEIMC-GESIDA

Academic / Other · 28 registered clinical trials.

StatusTrialPhaseStarted
CompletedStudy to Evaluate the Efficacy and Safety of a Rilpivarine-based Antiretroviral Tratment Regimen in HIV- Infec
HIV Infections, Fatty Liver Disease
Phase 42023-05-26
CompletedPhase IV, a Clinical Trial to Assess Safety and Convenience of the Change From DTG/3TC to BIC/FTC/TAF in Peopl
HIV Infections
Phase 42022-10-06
CompletedSimplified Model of Linkage and Retention to Care, Using a Mobile Unit and a Same-day Test and Treat Approach
HIV Infections
Phase 42022-07-04
CompletedLamivudine/Dolutegravir in Virologically Suppressed Subjects With Expected or Confirmed Resistance to Lamivudi
HIV Infections
Phase 22021-07-28
CompletedDTG/3TC vs. BIC/FTC/TAF Maintenance Therapy in People Living With HIV:
HIV-1-infection
Phase 42021-07-14
CompletedClinical Trial to Evaluate the Effectiveness and Safety of Tocilizumab for Treating Patients With COVID-19 Pne
COVID-19
Phase 22020-05-22
CompletedCharacteristics and Outcomes of Hospitalized Patients With COVID-19 in Spain
Covid19
2020-03-18
CompletedA Phase IV Study to Assess the Impact of the Change of Antiretroviral Treatment From Dual Therapy to Triple Th
HIV Infections
Phase 42019-10-10
CompletedBezlotoxumab - in "Real Life" - During the First Episode of Clostridium Difficile Infection in Patients With H
Clostridium Difficile Infection
2019-10-01
CompletedA Clinical Trial to Evaluate the Reversibility of Abacavir/Lamivudine/Dolutegravir CNS-Related Neurotoxicity A
HIV Infections
Phase 42018-12-04
CompletedA Clinical Trial to Evaluate the Immunogenicity of the Nonavalent Vaccine Against Human Papillomavirus in Men
HIV Infections
Phase 42018-10-15
Active Not RecruitingSpanish Cohort of Patients with HIV Infection Older Than 50 Years for the Study of Fragility and Physical Func
HIV Infections, Frail Older Adults
2018-05-07
CompletedA Clinical Trial to Evaluate the Efficacy and Safety of Elvitegravir / Cobicistat / Emtricitabine / Tenofovir
HIV Infections, Severe Immunosuppression
Phase 42018-04-13
CompletedA Phase IV, Open-label, Randomised, Pilot Clinical Trial Designed to Evaluate the Potential Neurotoxicity of D
HIV Infections
Phase 42017-09-08
WithdrawnA Clinical Trial of 16 Weeks of Duration to Evaluate Retreatment With Elbasvir/Grazoprevir Plus Sofosbuvir and
HCV
Phase 42017-07-01
CompletedStudy of the Effectiveness and Safety of Darunavir/Cobicistat (DRV/c) Containing Regimens in Routine Clinical
HIV Infections
2016-12-23
CompletedSwitching Strategy With Raltegravir + ABC / 3TC in Controlled HIV-1 Infection
HIV Infections
2016-11-15
CompletedStudy to Evaluate Darunavir/Ritonavir + Lamivudine Versus Continuing With Darunavir/Ritonavir + Tenofovir/Emtr
HIV Infection
Phase 42014-07-01
CompletedObservational, Retrospective, Multicenter Study to Describe the Reasons for the Change of the Regimen of Antir
HIV
2013-10-01
CompletedA Prospective, With One Site, Open-label Not Controled Trial, for the Observation of Treatment With CIDOFOVIR
HIV
N/A2013-09-01
UnknownRetrospective Study to Determine the Incidence of Bone Fractures in HIV-infected Patients in Spain
HIV
2013-06-01
CompletedProspective Population Study on Candidemia in Spain
Fungemia
2013-03-01
CompletedAnidulafungin vs Amphotericin B Safety in High Risk Hepatic Transplant Recipients
Liver Disease, Fungal Infection
Phase 42011-11-01
CompletedSimplification to Atazanavir/Ritonavir + Lamivudine as Maintenance Therapy
HIV Infection
Phase 42011-09-01
CompletedHCV Evolution in HIV/HCV (Genotype 1) Coinfected Patients Treated With Fosamprenavir
Chronic HIV Infection, HCV Coinfection
Phase 42011-03-01
CompletedPrevention of Lipoatrophy in Patients Treated With Lopinavir/Ritonavir in Monotherapy Versus ZDV + 3TC + ABC
HIV Infection, HIV Infections
Phase 42008-12-01
CompletedLopinavir/r Monotherapy Versus Abacavir/Lamivudine and Lopinavir/r for Limb Fat Recovery in Persons With Lipoa
HIV Infection, Lipodystrophy, HIV Infections
Phase 42008-12-01
CompletedTreatment of HIV/HCV Coinfection With Peg-IFN and Ribavirin in Patients Receiving ART Monotherapy With Lopinav
HIV/HCV Co-infection, HIV Infections
Phase 42008-02-01